Sysmex Corporation (TYO: 6869)

Market Cap	1.82T
Revenue (ttm)	491.29B
Net Income (ttm)	53.46B
Shares Out	623.51M
EPS (ttm)	85.65
PE Ratio	34.04
Forward PE	29.09
Dividend	30.00 (1.03%)
Ex-Dividend Date	Mar 28, 2025

Volume	2,915,800
Open	2,956.00
Previous Close	2,942.00
Day's Range	2,912.50 - 2,957.50
52-Week Range	2,138.00 - 3,236.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 12, 2025

About Sysmex

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers;...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1968
• Employees: 10,042
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 6869

Financial Performance

In 2023, Sysmex's revenue was 461.51 billion, an increase of 12.43% compared to the previous year's 410.50 billion. Earnings were 49.64 billion, an increase of 8.42%.